Loading clinical trials...
Loading clinical trials...
A 9 Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Study Of Pregabalin (BID) In Subject With Posttraumatic Peripheral Neuropathic Pain
Conditions
Interventions
pregabalin
Placebo
Locations
44
Belgium
Pfizer Investigational Site
Brussels, Belgium
Pfizer Investigational Site
Genk, Belgium
Pfizer Investigational Site
Liège, Belgium
Pfizer Investigational Site
Liège, Belgium
Pfizer Investigational Site
Pellenberg, Belgium
Pfizer Investigational Site
Wilrijk, Belgium
Start Date
January 1, 2006
Primary Completion Date
May 1, 2008
Completion Date
May 1, 2008
Last Updated
February 9, 2021
NCT06398847
NCT06290661
NCT04144972
NCT07000409
NCT06890897
NCT06896994
Lead Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions